Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.


Recent & Breaking News (NYSEAM:ZOM)

Zomedica Raises Over C$5.0 Million in First Tranche Closing of Equity Financing

GlobeNewswire August 25, 2016

Zomedica Pharmaceuticals Corp. Announces Second Quarter 2016 Financial Results

GlobeNewswire August 23, 2016

Zomedica Pharmaceuticals (V.ZOM) announces $15.0 million equity financing

Stockhouse Editorial August 17, 2016

Zomedica Announces C$15 Million Equity Financing

GlobeNewswire August 17, 2016

Zomedica Files U.S. Provisional Patent Application for Novel Pharmaceutical Formulation

GlobeNewswire July 12, 2016

Zomedica (V.ZOM) building to capitalize on multi-billion companion pet health

Gaalen Engen June 9, 2016

Zomedica Pharmaceuticals Corp. Announces First Quarter 2016 Financial Results of ZoMedica Pharmaceuticals Inc.

GlobeNewswire May 26, 2016

Zomedica (V.ZOM) inks research collaboration agreement with CTX Technology

Stockhouse Editorial May 17, 2016

Zomedica Announces Joint Research Collaboration with CTX Technology, Inc.

GlobeNewswire May 17, 2016

Zomedica Opens First Investigational New Animal Drug Application with FDA Center for Veterinary Medicine

Globe Newswire May 10, 2016

Zomedica Pharmaceuticals Corp. Opens the Market

Canada NewsWire May 3, 2016

Zomedica Pharmaceuticals (V.ZOM) commences trading on the TSX Venture Exchange

Stockhouse Editorial May 3, 2016

Zomedica Now Trading on TSX Venture Exchange

GlobeNewswire May 2, 2016

Vet pharma pioneer Zomedica (V.ZOM) completes qualifying transaction

Stockhouse Editorial April 28, 2016

Zomedica Announces Completion of Qualifying Transaction

GlobeNewswire April 27, 2016

ZoMedica To Complete Listing Transaction on TSX Venture Exchange

Stockhouse.com April 13, 2016

ZoMedica Pharmaceuticals (V.ZOM) to complete TSX Venture listing

Stockhouse Editorial April 13, 2016

Wise Oakwood Ventures Inc. Announces Formal Agreement with ZoMedica Pharmaceuticals Inc., Conditional Exchange Acceptance and Filing Statement

Stockhouse.com March 30, 2016

Wise Oakwood Ventures Inc. Provides Extension Update

Stockhouse.com January 28, 2016

Wise Oakwood Ventures Inc. Announces Letter of Intent with Zomedica Pharmaceuticals Inc.

Stockhouse.com December 4, 2015